Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 2:22 pm Purchase | 13G | OVID THERAPEUTICS INC OVID | Consonance Capital Management LP | 6,058,505 11% | 3,169,617 (+109.72%) | View |
2021-02-16 2:21 pm Purchase | 13G | OMEROS CORPORATION OMER | Consonance Capital Management LP | 6,058,505 11% | 2,862,709 (+89.58%) | View |
2021-02-16 2:21 pm Purchase | 13G | LIMINAL BIOSCIENCES INC LMNL | Consonance Capital Management LP | 6,058,505 11% | 2,771,194 (+84.30%) | View |
2021-02-16 2:21 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Consonance Capital Management LP | 6,058,505 11% | -68,929 (-1.12%) | View |
2021-02-16 2:21 pm Sale | 13G | KADMON HLDGS LLC COM KDMN | Consonance Capital Management LP | 6,834,770 9.99% | -8,807,294 (-56.31%) | View |
2021-02-16 2:21 pm Purchase | 13G | IVERIC BIO INC ISEE | Consonance Capital Management LP | 6,058,505 9.99% | 2,632,140 (+76.82%) | View |
2021-02-16 2:21 pm Purchase | 13G | GENMARK DIAGNOSTICS INC GNMK | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
2021-02-16 2:21 pm Purchase | 13G | GAMIDA CELL LTD GMDA | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
2021-02-16 2:20 pm Purchase | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU | Consonance Capital Management LP | 6,058,505 9.99% | 4,624,505 (+322.49%) | View |
2021-02-16 2:20 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
2021-02-16 2:20 pm Purchase | 13G | CASI PHARMACEUTICALS INC CASI | Consonance Capital Management LP | 6,058,505 9.99% | 6,058,505 (New Position) | View |
2021-02-16 2:20 pm Purchase | 13G | CAREDX INC CDNA | Consonance Capital Management LP | 6,058,505 11% | 3,936,529 (+185.51%) | View |
2021-02-16 2:20 pm Purchase | 13G | AXOGEN, INC. AXGN | Consonance Capital Management LP | 6,058,505 11% | 3,072,119 (+102.87%) | View |
2021-02-16 2:19 pm Sale | 13G | AURINIA PHARMACEUTICALS INC AUPH | Consonance Capital Management LP | 6,058,505 11% | -567,166 (-8.56%) | View |
2021-02-16 2:19 pm Sale | 13G | ARQULE INC ARQL | Consonance Capital Management LP | 6,058,505 11% | -679,701 (-10.09%) | View |
2021-02-16 2:11 pm Sale | 13G | ADMA BIOLOGICS INC ADMA | Consonance Capital Management LP | 1,558,290 1.65% | -3,608,671 (-69.84%) | View |
2020-12-03 1:40 pm Purchase | 13D | CONSONANCE-HFW ACQUISITION COR CHFWU | Consonance Capital Management LP | 1,434,000 14.9% | 1,434,000 (New Position) | View |
2020-11-05 4:55 pm Sale | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Consonance Capital Management LP | 1,252,229 3.99% | -988,550 (-44.12%) | View |
2020-06-16 09:37 am Purchase | 13G | KINIKSA PHARMACEUTICALS LTD KNSA | Consonance Capital Management LP | 2,240,779 11% | 2,240,779 (New Position) | View |
2020-02-14 5:12 pm Sale | 13G | LUMINEX CORPORATION LMNX | Consonance Capital Management LP | 0 0% | -2,402,787 (Position Closed) | View |